Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Flu Vaccine”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00133588
What this trial is testing

Proteomic Profiling for Influenza

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 150
Testing effectiveness (Phase 2)Study completedNCT02213354
What this trial is testing

H7N9 Mix and Match With MF59 in Healthy Elderly Persons

Who this might be right for
Avian Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 479
Large-scale testing (Phase 3)Study completedNCT02467842
What this trial is testing

Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects

Who this might be right for
Influenza
SK Chemicals Co., Ltd. 1,503
Testing effectiveness (Phase 2)UnknownNCT02247362
What this trial is testing

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

Who this might be right for
Influenza
VaxInnate Corporation 200
Post-approval studies (Phase 4)Study completedNCT00735475
What this trial is testing

Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

Who this might be right for
Influenza
Seqirus 1,268
Testing effectiveness (Phase 2)Study completedNCT00778895
What this trial is testing

Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control

Who this might be right for
Influenza
GlaxoSmithKline 390
Early research (Phase 1)Study completedNCT00973895
What this trial is testing

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Who this might be right for
Influenza A Virus, H1N1 SubtypeNovel Swine-Origin
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT06840236
What this trial is testing

Digital Health Intervention On Awareness Of Vaccination Against Influenza Among Adults With Diabetes

Who this might be right for
Diabetes Mellitus Self Management EducationDiabetes
LabStyle Innovations Ltd. 8,431
Not applicableStudy completedNCT04723771
What this trial is testing

Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020

Who this might be right for
Influenza in Human
University of Athens 949
Early research (Phase 1)Study completedNCT01806909
What this trial is testing

Intranasal AD4-H5-VTN as an Adenovirus Vaccine

Who this might be right for
Healthy Volunteer
National Institute of Allergy and Infectious Diseases (NIAID) 51
Testing effectiveness (Phase 2)Study completedNCT02307851
What this trial is testing

Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults

Who this might be right for
Influenza
Novavax 400
Testing effectiveness (Phase 2)Study completedNCT06695130
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Large-scale testing (Phase 3)Not Yet RecruitingNCT07133802
What this trial is testing

Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

Who this might be right for
Prevention of Influenza
Changchun BCHT Biotechnology Co. 6,680
Post-approval studies (Phase 4)Active Not RecruitingNCT07232745
What this trial is testing

Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine

Who this might be right for
Influenza
Jiangsu Province Centers for Disease Control and Prevention 60
Testing effectiveness (Phase 2)Study completedNCT00306995
What this trial is testing

Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 385
Large-scale testing (Phase 3)Study completedNCT01057771
What this trial is testing

Meditation and Exercise for Prevention of Acute Respiratory Infection

Who this might be right for
Acute Respiratory Infection
University of Wisconsin, Madison 154
Large-scale testing (Phase 3)Study completedNCT00128167
What this trial is testing

Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

Who this might be right for
Influenza
MedImmune LLC 8,500
Early research (Phase 1)UnknownNCT02015494
What this trial is testing

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

Who this might be right for
Influenza
VaxInnate Corporation 316
Early research (Phase 1)UnknownNCT06046092
What this trial is testing

H7HLAII DNA Influenza Vaccine

Who this might be right for
Influenza APandemic Influenza
Oslo University Hospital 27
Early research (Phase 1)Study completedNCT00559975
What this trial is testing

Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine

Who this might be right for
Influenza Infection
Novartis 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation